Quality and applicability assessment for systematic reviews on acupuncture treatment for primary depression_Chinese Journal of Evidence-Based Medicine

Authors：

XU Guixing , LI Juan , YIN Zihan , LI Yuxi , FU Yanan , ZHOU Jun ,  LIANG Fanrong

Chengdu University of Traditional Chinese Medicine, Chengdu 610041, P.R.China;

Corresponding?author：

LIANG Fanrong, Email: acuresearch@126.com

Keywords：

Primary depression; Acupuncture; Review of systematic reviews; Assessment of multiple systematic reviews (AMSTAR); Risk of bias in systematic review (ROBIS); Critical appraisal skill program in systematic review (CASP-S.R)

DOI：

10.7507/1672-2531.201903092

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To comprehensively evaluate the methodological quality and applicability of the results of systematic reviews on acupuncture treatment for primary depression.Methods Web of Science, EMbase, PubMed, The Cochrane Library, CNKI, CBM, WanFang Data and VIP databases were electronically searched to collect systematic reviews/meta-analyses on acupuncture treatment for primary depression from inception to December 5^th, 2018. Two researchers independently screened and extracted data by using tools of AMSTAR 2 to evaluate the methodological quality, using ROBIS to assess risk of bias, and using CASP-S.R to evaluate the applicability of the results.Results A total of 18 systematic reviews/meta-analyses were included, and all focused on acupuncture intervention, including 2 primary outcome indicators. According to AMSTAR 2 evaluation results, there were 4 high quality studies, 12 medium quality studies and 2 low quality studies; ROBIS results found 10 high bias risk studies, 7 low bias risk studies and 1 unclear; CASP-S.R showed only 4 design studies applicable to local individuals, and there were no studies on the relationship between design benefits, hazards and costs.Conclusions The quality of systematic reviews/meta-analyses for acupuncture treatment of primary depression is moderate, however with a certain bias. Most studies may not directly benefit local individuals. All studies have no relationship with cost hazards. It is expected for further reviewers to strictly follow systematic evaluation method to improve research quality and reduce bias, while the applicability of the systematic review to individuals from different regions should be considered as well as the relationship between the benefit and cost hazard. In addition, more valid RCTs are required to provide higher quality evidence and explore correlated and comprehensive mechanism.

Citation： XU Guixing, LI Juan, YIN Zihan, LI Yuxi, FU Yanan, ZHOU Jun, LIANG Fanrong. Quality and applicability assessment for systematic reviews on acupuncture treatment for primary depression. Chinese Journal of Evidence-Based Medicine, 2019, 19(11): 1333-1340. doi: 10.7507/1672-2531.201903092 Copy

1.	中華醫學會精神科分會. 中國精神障礙分類與診斷標準 (第 3 版). 濟南: 山東科學技術出版社, 2001.
2.	Holden C. Mental health. Global survey examines impact of depression. Science, 2000, 288(5463): 39-40.
3.	Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science, 1996, 274(5288): 740-743.
4.	范毅. 選擇性 5-羥色胺再攝取抑制劑類藥物的研究進展. 藥物評價研究, 2012, 35(2): 126-129.
5.	Metternich B, Kosch D, Kriston L, et al. The effects of nonpharmacological interventions on subjective memory complaints: a systematic review and meta-analysis. Psychother Psychosom, 2010, 79(1): 6-19.
6.	Marcus D. Managing headache during pregnancy and lactation. Expert Rev Neurother, 2008, 8(3): 385-395.6.
7.	張俊華, 商洪才, 張伯禮. 系統評價和 Meta 分析質量的評價方法. 中西醫結合學報, 2008, 6(4): 337-340.7.
8.	曾憲濤, 黃偉, 田國祥. Meta 分析系列之九: Meta 分析的質量評價工具. 中國循證心血管醫學雜志, 2013, 5(1): 3-5.8.
9.	Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007, 7: 10.
10.	陶歡, 楊樂天, 平安, 等. 隨機或非隨機防治性研究系統評價的質量評價工具 AMSTAR 2 解讀. 中國循證醫學雜志, 2018, 18(1): 101-108.
11.	丁泓帆, 吳瓊芳, 楊楠, 等. 評估系統評價偏倚風險的 ROBISIS 工具實例解讀. 中國循證醫學雜志, 2016, 16(01): 115-121.
12.	吳瓊芳, 丁泓帆, 鄧圍, 等. ROBIS: 評估系統評價偏倚風險的新工具. 中國循證醫學雜志, 2015, 15(12): 1454-1457.
13.	高木健, 趙雪, 陳波, 等. 基于 GRADE 系統的針灸治療抑郁癥隨機對照試驗臨床證據的評價研究. 中國針灸學會刺絡與拔罐專業委員會第二屆學術交流大會論文集. 2012: 118-122.
14.	樊凌. 針灸治療抑郁癥的文獻評價和臨床研究. 廣州: 廣州中醫藥大學, 2011.
15.	張迪. 針刺治療抑郁失眠共病隨機對照試驗的系統評價. 黑龍江中醫藥大學, 2017.
16.	王瓏, 孫冬瑋, 鄒偉, 等. 針刺治療抑郁癥療效與安全性的系統評價. 中國針灸, 2008, 28(5): 381-386.
17.	Nguyen BQ, Nghiem HT, Ngo QH, et al. 針灸與五羥色胺再攝取抑制劑 (SSRI) 類藥物改善抑郁癥患者生活質量的 Meta 分析. 世界最新醫學信息文摘, 2017, 17(99): 120-124.
18.	宋洪濤, 武忠, 張瑞霞. 針刺督脈穴位治療抑郁癥的 Meta 分析. 國際醫藥衛生導報, 2017, 23(2): 250-253.
19.	沈慧, 張捷, 楊婧, 等. 針刺治療抑郁癥隨機對照研究的系統評價. 新中醫, 2014, 46(6): 220-222.
20.	黎波, 杜元灝, 王栩, 等. 針刺治療原發性抑郁癥干預方式研究: Meta 分析與層次分析法. 中國針灸, 2013, (5): 463-467.
21.	邊興坤, 傅立新, 左小宏, 等. 針刺與藥物治療抑郁癥療效比較的系統評價. 針灸臨床雜志, 2011, 27(8): 59-62.
22.	熊俊, 杜元灝, 劉佳琳, 等. 針灸與西藥治療抑郁性神經癥療效比較的系統評價. 中國循證醫學雜志, 2009, 9(9): 969-975.
23.	鐘寶亮, 黃悅勤, 李會娟. 針灸治療抑郁癥療效和安全性的系統評價. 中國心理衛生雜志, 2008, 22(9): 641-647.
24.	孫燕麗, 陳爽白, 高軼, 等. 國內針刺與西藥治療抑郁癥療效比較的系統評價. 中國循證醫學雜志, 2008, 8(5): 340-345.
25.	Dong B, Chen Z, Yin X, et al. The efficacy of acupuncture for treating depression-related insomnia compared with a control group: a systematic review and meta-analysis. Biomed Res Int, 2017: 9614810.
26.	Chan YY, Lo WY, Yang SN, et al. The benefit of combined acupuncture and antidepressant medication for depression: A systematic review and meta-analysis. J Affect Disord, 2015, 176: 106-117.
27.	Fan L, Fu W, Xu N, et al. Meta-analysis of 20 clinical, randomized, controlled trials of acupuncture for depression. Neural Regen Res, 2010, 5(24): 1862-1869.
28.	Wang H, Qi H, Wang BS, et al. Is acupuncture beneficial in depression: a meta-analysis of 8 randomized controlled trials? J Affect Disord, 2008, 111(2-3): 125-134.
29.	Mukaino Y, Park J, White A, et al. The effectiveness of acupuncture for depression--a systematic review of randomised controlled trials. Acupunct Med, 2005, 23(2): 70-76.
30.	Zhang ZJ, Chen HY, Yip KC, et al. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord, 2010, 124(1-2): 9-21.

1. 中華醫學會精神科分會. 中國精神障礙分類與診斷標準 (第 3 版). 濟南: 山東科學技術出版社, 2001.
2. Holden C. Mental health. Global survey examines impact of depression. Science, 2000, 288(5463): 39-40.
3. Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science, 1996, 274(5288): 740-743.
4. 范毅. 選擇性 5-羥色胺再攝取抑制劑類藥物的研究進展. 藥物評價研究, 2012, 35(2): 126-129.
5. Metternich B, Kosch D, Kriston L, et al. The effects of nonpharmacological interventions on subjective memory complaints: a systematic review and meta-analysis. Psychother Psychosom, 2010, 79(1): 6-19.
6. Marcus D. Managing headache during pregnancy and lactation. Expert Rev Neurother, 2008, 8(3): 385-395.6.
7. 張俊華, 商洪才, 張伯禮. 系統評價和 Meta 分析質量的評價方法. 中西醫結合學報, 2008, 6(4): 337-340.7.
8. 曾憲濤, 黃偉, 田國祥. Meta 分析系列之九: Meta 分析的質量評價工具. 中國循證心血管醫學雜志, 2013, 5(1): 3-5.8.
9. Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007, 7: 10.
10. 陶歡, 楊樂天, 平安, 等. 隨機或非隨機防治性研究系統評價的質量評價工具 AMSTAR 2 解讀. 中國循證醫學雜志, 2018, 18(1): 101-108.
11. 丁泓帆, 吳瓊芳, 楊楠, 等. 評估系統評價偏倚風險的 ROBISIS 工具實例解讀. 中國循證醫學雜志, 2016, 16(01): 115-121.
12. 吳瓊芳, 丁泓帆, 鄧圍, 等. ROBIS: 評估系統評價偏倚風險的新工具. 中國循證醫學雜志, 2015, 15(12): 1454-1457.
13. 高木健, 趙雪, 陳波, 等. 基于 GRADE 系統的針灸治療抑郁癥隨機對照試驗臨床證據的評價研究. 中國針灸學會刺絡與拔罐專業委員會第二屆學術交流大會論文集. 2012: 118-122.
14. 樊凌. 針灸治療抑郁癥的文獻評價和臨床研究. 廣州: 廣州中醫藥大學, 2011.
15. 張迪. 針刺治療抑郁失眠共病隨機對照試驗的系統評價. 黑龍江中醫藥大學, 2017.
16. 王瓏, 孫冬瑋, 鄒偉, 等. 針刺治療抑郁癥療效與安全性的系統評價. 中國針灸, 2008, 28(5): 381-386.
17. Nguyen BQ, Nghiem HT, Ngo QH, et al. 針灸與五羥色胺再攝取抑制劑 (SSRI) 類藥物改善抑郁癥患者生活質量的 Meta 分析. 世界最新醫學信息文摘, 2017, 17(99): 120-124.
18. 宋洪濤, 武忠, 張瑞霞. 針刺督脈穴位治療抑郁癥的 Meta 分析. 國際醫藥衛生導報, 2017, 23(2): 250-253.
19. 沈慧, 張捷, 楊婧, 等. 針刺治療抑郁癥隨機對照研究的系統評價. 新中醫, 2014, 46(6): 220-222.
20. 黎波, 杜元灝, 王栩, 等. 針刺治療原發性抑郁癥干預方式研究: Meta 分析與層次分析法. 中國針灸, 2013, (5): 463-467.
21. 邊興坤, 傅立新, 左小宏, 等. 針刺與藥物治療抑郁癥療效比較的系統評價. 針灸臨床雜志, 2011, 27(8): 59-62.
22. 熊俊, 杜元灝, 劉佳琳, 等. 針灸與西藥治療抑郁性神經癥療效比較的系統評價. 中國循證醫學雜志, 2009, 9(9): 969-975.
23. 鐘寶亮, 黃悅勤, 李會娟. 針灸治療抑郁癥療效和安全性的系統評價. 中國心理衛生雜志, 2008, 22(9): 641-647.
24. 孫燕麗, 陳爽白, 高軼, 等. 國內針刺與西藥治療抑郁癥療效比較的系統評價. 中國循證醫學雜志, 2008, 8(5): 340-345.
25. Dong B, Chen Z, Yin X, et al. The efficacy of acupuncture for treating depression-related insomnia compared with a control group: a systematic review and meta-analysis. Biomed Res Int, 2017: 9614810.
26. Chan YY, Lo WY, Yang SN, et al. The benefit of combined acupuncture and antidepressant medication for depression: A systematic review and meta-analysis. J Affect Disord, 2015, 176: 106-117.
27. Fan L, Fu W, Xu N, et al. Meta-analysis of 20 clinical, randomized, controlled trials of acupuncture for depression. Neural Regen Res, 2010, 5(24): 1862-1869.
28. Wang H, Qi H, Wang BS, et al. Is acupuncture beneficial in depression: a meta-analysis of 8 randomized controlled trials? J Affect Disord, 2008, 111(2-3): 125-134.
29. Mukaino Y, Park J, White A, et al. The effectiveness of acupuncture for depression--a systematic review of randomised controlled trials. Acupunct Med, 2005, 23(2): 70-76.
30. Zhang ZJ, Chen HY, Yip KC, et al. The effectiveness and safety of acupuncture therapy in depressive disorders: systematic review and meta-analysis. J Affect Disord, 2010, 124(1-2): 9-21.

Chinese Journal of Evidence-Based Medicine

Quality and applicability assessment for systematic reviews on acupuncture treatment for primary depression

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content